|Page (1) of 1 - 08/16/18||email article||print page|
(August 16, 2018)
The Global Blood Plasma Derivatives Market is expected to reach US$ 58.2 Billion in 2023 from US$ 30.5 Billion in 2016 with a CAGR of approximately 7.52% during the forecast period 2017-2023. Blood plasma derivatives have a wide range of applications thus increasing their demand in the market. They are used in various diseases like HIV, hepatitis B and Hepatitis C. Plasma derivatives are collected from large number of donors for their use in patients suffering from life threatening diseases. Hence the importance of blood plasma derivatives has increased in healthcare.
Global Blood Plasma Derivatives Market has been segmented on the basis of type which includes albumin, anti-thrombin, intravenous immunoglobulin (IVIG), fresh frozen plasma (FFP) and others. Others types are Factor VII, Factor IX and Alpha 1 proteinase inhibitor concentrate. On the basis on application the market is segmented into Hemophilia A, Hemophilia B, HIV, Hepatitis B, Hepatitis C, Thrombocytosis, and others. Other application includes Von Willebrand disease. End users include hospitals, clinics, diagnostic centers, blood transfusion centers and others.
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1325 .
Key Players for Blood Plasma Derivatives Market:
SK Plasma (Korea),
Fusion Healthcare (India),
Baxter International Inc. (U.S),
CSL Limited (Australia),
Octapharma AG (Germany),
Biotest AG (Germany) and Bain Capital (U.S).
Blood Plasma Derivatives Companies
Research and Development (R&D) Companies
Medical Research Laboratories
Blood transfusion centers
Academic Medical Institutes and Universities
Regional Analysis of Blood Plasma Derivatives Market:
Globally, Blood Plasma Derivatives Market consists of four regions North America, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market for syringe and needle. The North American market for Blood Plasma Derivatives is expected to grow at a CAGR of 4.25% which is expected to reach at US$ 35.50 billion from US$ 20 billion in 2016 by the end of the forecasted period. Awareness regarding use of plasma derivatives for patients suffering from infectious diseases drive this market in North America. Europe is the second-largest market for Blood Plasma Derivatives which is expected to grow at a CAGR of 3.8%. Extensive research on safe blood transfusion in healthcare organizations and research laboratories favor the growth of this market in Europe. Whereas Asia Pacific is expected to be the fastest growing market for Blood Plasma Derivatives market. India is expected to be the emerging and fastest growing market. Demand for plasma derivatives for inactivation of HIV favor the demand of plasma derivatives in Asia-pacific. The market shows steady growth in Middle East and Africa.
Major Table Of Contents For Blood Plasma Derivatives Market Report:
1 Report Prologue
2 Market Introduction
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
Get Discount @ https://www.marketresearchfuture.com/check-discount/1325 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research FutureContact Person: Abhishek Sawant
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
Related Keywords:Australia,Business,Health & Medicine,Science,U.S,
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter